PT  - JOURNAL ARTICLE
AU  - Solis, Juan Frausto
AU  - Vazquez, José Enrique Olvera
AU  - Barbosa, Juan J González
AU  - Valdez, Guadalupe Castilla
AU  - Hernández, Juan Paulo Sánchez
AU  - Perez-Ortega, Joaquín
TI  - The Hybrid Forecasting Method SVR-ESAR for Covid-19
AID  - 10.1101/2020.05.20.20103200
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.20.20103200
4099  - http://medrxiv.org/content/early/2020/05/22/2020.05.20.20103200.short
4100  - http://medrxiv.org/content/early/2020/05/22/2020.05.20.20103200.full
AB  - We know that SARS-Cov2 produces the new COVID-19 disease, which is one of the most dangerous pandemics of modern times. This pandemic has critical health and economic consequences, and even the health services of the large, powerful nations may be saturated. Thus, forecasting the number of infected persons in any country is essential for controlling the situation. In the literature, different forecasting methods have been published, attempting to solve the problem. However, a simple and accurate forecasting method is required for its implementation in any part of the world. This paper presents a precise and straightforward forecasting method named SVR-ESAR (Support Vector regression hybridized with the classical Exponential smoothing and ARIMA). We applied this method to the infected time series in four scenarios, which we have taken for the Github repository: the Whole World, China, the US, and Mexico. We compared our results with those of the literature showing the proposed method has the best accuracy.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study forecast the number of infected and we do not use personal data of themFunding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We have not used patients data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in this study are described in the manuscript. We have not used clinical trials and neither any other prospective interventional study. https://github.com/CSSEGISandData/COVID19/blob/master/archived_data/archived_time_series/time_series_19-covid-Confirmed_archived_0325.csv